Wave Life Sciences Ltd (WVE)

Currency in USD
3.790
-0.090(-2.32%)
Real-time Data·

WVE Earnings

Latest Release
Jul 30, 2026
EPS / Forecast
-0.34 / -0.30
Revenue / Forecast
2.3M / 7.65M
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
2026/09--/-0.319--/7.24M----Free Sign Up
2026/06-0.340/-0.3002.30M/7.65M-13.33%-69.93%Free Sign Up
2026/03-0.130/-0.32038.25M/8.34M+59.38%+358.63%Free Sign Up
2025/12-0.300/-0.27017.24M/17.16M-11.11%+0.47%Free Sign Up
2025/09-0.320/-0.2557.61M/12.89M-25.64%-40.96%Free Sign Up
2025/06-0.310/-0.2708.70M/14.31M-14.81%-39.2%Free Sign Up
2025/03-0.290/-0.2509.18M/11.95M-16%-23.18%Free Sign Up
2024/120.170/-0.17083.75M/20.72M+200%+304.2%Free Sign Up
2024/09-0.470/-0.283-7.68M/16.61M-66.2%-146.24%Free Sign Up
2024/06-0.250/-0.21019.69M/19.45M-19.05%+1.23%Free Sign Up

All numbers in USD

Wave Life Sciences Ltd Earnings Call Summary for Q2/2026

  • Wave Life Sciences posted Q2 2026 loss of $0.34/share vs. $0.30 estimate; revenue fell 73.6% to $2.3M, missing $7.65M forecast by 70%.
  • R&D spending rose 18% to $51.3M and G&A jumped 37.8% to $24.8M as company advanced WVE-007, WVE-006, and WVE-008 pipeline programs.
  • Company holds $490.6M in cash, sufficient to fund operations through Q3 2028; expects GSK milestone payments in H2 2026.
  • FDA granted meeting for late summer to discuss potential accelerated approval pathway for WVE-006 in AATD; WVE-007 Phase IIa enrollment ongoing.
  • Shares fell 2.75% to $5.65, near 52-week low of $5.02; stock down 66% YTD despite analyst price targets ranging from $12 to $43.
Last Updated: 2026-07-30, 10:00 a/m
Read Full Transcript

FAQ

What Is Wave Life Sciences Ltd's Earnings Per Share (TTM)?

The Wave Life Sciences Ltd EPS (TTM) is -1.077.

When Is The Next Wave Life Sciences Ltd Earnings Date?

Wave Life Sciences Ltd will release its next earnings report on Nov 05, 2026.

What Is Wave Life Sciences Ltd’s Revenue Forecasts For Upcoming Quarters?

Wave Life Sciences Ltd’s revenue forecast is 7.24M.

How Did Wave Life Sciences Ltd React to the Company's Latest Earnings Report?

Wave Life Sciences Ltd reported a -13.33% EPS surprise and a -69.93% revenue surprise, comparing the latest report against analyst forecasts. The stock price changed by -5.160%, reflecting the market's response to the earnings results.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.